Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to $163.6 million.

  • Usana Health Sciences' Operating Expenses rose 1256.72% to $163.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $680.8 million, marking a year-over-year increase of 1076.82%. This contributed to the annual value of $627.0 million for FY2024, which is 372.81% down from last year.
  • Per Usana Health Sciences' latest filing, its Operating Expenses stood at $163.6 million for Q3 2025, which was up 1256.72% from $168.9 million recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Operating Expenses ranged from a high of $248.3 million in Q1 2022 and a low of $145.4 million during Q3 2024
  • For the 5-year period, Usana Health Sciences' Operating Expenses averaged around $176.5 million, with its median value being $168.9 million (2025).
  • As far as peak fluctuations go, Usana Health Sciences' Operating Expenses soared by 3166.11% in 2021, and later crashed by 3597.17% in 2022.
  • Over the past 5 years, Usana Health Sciences' Operating Expenses (Quarter) stood at $182.9 million in 2021, then fell by 13.06% to $159.0 million in 2022, then fell by 2.79% to $154.5 million in 2023, then grew by 7.96% to $166.8 million in 2024, then decreased by 1.93% to $163.6 million in 2025.
  • Its Operating Expenses stands at $163.6 million for Q3 2025, versus $168.9 million for Q2 2025 and $181.4 million for Q1 2025.